Literature DB >> 10465481

Complete resolution of angiosarcoma of the scalp with liposomal daunorubicin and radiotherapy.

K J Lankester1, R S Brown, M F Spittle.   

Abstract

Angiosarcoma of the head and neck is a rare malignant vascular tumour that predominantly affects elderly men and generally has a poor prognosis. Complete responses to treatment for larger tumours are uncommon. A patient with an extensive tumour that showed a complete response to combination therapy with liposomal daunorubicin and radiotherapy is presented. The rationale for using liposomal chemotherapy agents in the treatment of vascular tumours such as angiosarcoma is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465481     DOI: 10.1053/clon.1999.9046

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  5 in total

1.  The importance of surgery in scalp angiosarcomas.

Authors:  Richard J Cassidy; Jeffrey M Switchenko; Melinda L Yushak; Nicholas Madden; Mohammad K Khan; David K Monson; Jonathan J Beitler; Jerome C Landry; Karen D Godette; Theresa W Gillespie; Kirtesh R Patel
Journal:  Surg Oncol       Date:  2018-09-13       Impact factor: 3.279

2.  An uncommon profile of a case of angiosarcoma of scalp and face.

Authors:  N K Saidha; Pauline Babu; P Jaiswal; M S Suresh; K Lekshmi Priya; A Sen
Journal:  Indian J Surg Oncol       Date:  2013-03-08

3.  Atypical presentation of angiosarcoma of the scalp in the setting of human immunodeficiency virus (HIV).

Authors:  Poovandren S Govender
Journal:  World J Surg Oncol       Date:  2009-12-18       Impact factor: 2.754

4.  Scalp Angiosarcoma Remission with Bevacizumab and Radiotherapy without Surgery: A Case Report and Review of the Literature.

Authors:  Jocelyn T De Yao; Danyu Sun; Angela T Powell; Esther H Rehmus
Journal:  Sarcoma       Date:  2011-05-02

5.  Successful treatment of an angiosarcoma of the nose with radiation therapy.

Authors:  Vatsal B Patel; Tod W Speer
Journal:  Case Rep Oncol       Date:  2012-10-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.